Literature DB >> 31447211

Acute shortening versus bone transport for the treatment of infected femur non-unions with bone defects.

Cengiz Sen1, Mehmet Demirel2, Yavuz Sağlam3, Halil I Balcı4, Levent Eralp5, Mehmet Kocaoğlu6.   

Abstract

BACKGROUND: The bone transport technique has been a well-known method in the treatment of osteomyelitis of the long bones with large segmental bone defects. However, one of the major drawbacks with this traditional technique is the long-lasting consolidation period, which may entail infectious and non-infectious complications. To overcome this drawback, several techniques were developed, one of which is acute shortening and re-lengthening. The aims of this study were: 1) to present our experience with a new modified technique of acute shortening and re-lengthening using a monolateral external fixator combined with a retrograde intramedullary nail, and 2) to compare its results with the classic Ilizarov bone transport method in the management of infected non-unions of the distal femur with bone loss.
METHODS: This retrospective study compared these two techniques. 17 patients were treated using our modified technique of acute shortening and re-lengthening (Group A); 15 patients were treated using segmental bone transport (Group B). The average follow-up was 66 months (range: 24-180) in Group A and 70 months (range: 24-240) in Group B. The mean bone loss was 5.5 cm (range: 3-10) in Group A and 5.9 cm (range: 3-10) in Group B. The primary outcome of the present study was to compare the external fixator time (EFT) and external fixation index (EFI) between the two groups. The bone and functional status were also assessed.
RESULTS: The mean EFI was lower in Group A (mean: 31.8 days/cm; range: 24-50) than in Group B (mean 48.7 days/cm; range: 40-100) (p = 0.02). The mean EFT was shorter in Group A (mean: 120 days; range: 100-150) than in Group B (mean: 290 days; range: 100-400) (p = 0.0003). With respect to the bone and functional results, no difference was observed.
CONCLUSIONS: Although both techniques could be employed safely in the treatment of infected non-union of the distal femur with size defects ranging between 3 cm and 10 cm, our modified technique of acute shortening and re-lengthening may confer greater patient satisfaction because of shorter EFI.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute shortening; Bone defect; Bone transport; Infected non-unions of the femur

Mesh:

Year:  2019        PMID: 31447211     DOI: 10.1016/j.injury.2019.08.021

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  5 in total

1.  All Internal Bone Transport: Use of a Lengthening Nail and Double Plating for Management of Femoral Bone Loss.

Authors:  Jonathan Wright; Peter Bates; Nima Heidari; Alexandros Vris
Journal:  Strategies Trauma Limb Reconstr       Date:  2019 May-Aug

2.  Evaluation of complications associated with bifocal bone transport as treatment for either proximal, intermediate or distal femoral defects caused by infection: outcome analysis of 76 patients.

Authors:  Cong Peng; Kai Liu; Qi Tian; Maimaitiaili Tusunniyazi; Weiqi Kong; Haopeng Luan; Xiaokang Liu; Yan Zhao
Journal:  BMC Musculoskelet Disord       Date:  2022-02-09       Impact factor: 2.362

3.  Acute shortening and re-lengthening versus antibiotic calcium sulfate-loaded bone transport for the management of large segmental tibial defects after trauma.

Authors:  Qiang Huang; YiBo Xu; Yao Lu; Cheng Ren; Lu Liu; Ming Li; Qian Wang; Zhong Li; HanZhong Xue; Kun Zhang; Teng Ma
Journal:  J Orthop Surg Res       Date:  2022-04-10       Impact factor: 2.359

Review 4.  Evolution and Development of Ilizarov Technique in the Treatment of Infected Long Bone Nonunion with or without Bone Defects.

Authors:  Jun Li; Mingxin Li; Wenzhao Wang; Bohua Li; Lei Liu
Journal:  Orthop Surg       Date:  2022-03-27       Impact factor: 2.279

5.  Shortening and re-lengthening versus bone transport for the treatment of distal tibial periarticular post-traumatic defects.

Authors:  Qiang Huang; Teng Ma; Cheng Ren; YiBo Xu; Ming Li; Qian Wang; Yao Lu; Zhong Li; Kun Zhang
Journal:  Sci Rep       Date:  2022-09-29       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.